Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects




Saari TI, Laine K, Leino K, Valtonen M, Neuvonen PJ, Olkkola KT

PublisherBLACKWELL PUBLISHING

2007

British Journal of Clinical Pharmacology

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

BRIT J CLIN PHARMACO

63

1

116

120

5

0306-5251

DOIhttps://doi.org/10.1111/j.1365-2125.2006.02707.x



Conclusion: Voriconazole caused a moderate increase in exposure to zolpidem in healthy young subjects but no clear pharmacodynamic changes were observed between the groups.

Last updated on 2024-26-11 at 21:36